NAD+ Nicotinamide Adenine Dinucleotide recall
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate…
Why was NAD+ Nicotinamide Adenine Dinucleotide recalled?
Product found to be Sub Potent or Exceeded reconstitution time
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22
- Product
- NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate…
- Recalling firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Quantity
- 2634 vials
- Distribution
- Nationwide in the USA including Puerto Rico.
- Recall date
- March 30, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)